MO
62
5
PH
78
-2
GS
79
-4
MRO
43
-3
QCOM
57
-3
DVN
25
-3
ETN
83
-3
DOW
28
-2
BLK
72
-4
NSC
62
-3
MHK
48
-5
KMB
28
-2
AN
52
-2
JNPR
56
-2
VTR
55
-2
JNJ
38
-3
CNP
52
5
PM
56
-2
MMC
65
3
PLD
48
-2
MO
62
5
PH
78
-2
GS
79
-4
MRO
43
-3
QCOM
57
-3
DVN
25
-3
ETN
83
-3
DOW
28
-2
BLK
72
-4
NSC
62
-3
MHK
48
-5
KMB
28
-2
AN
52
-2
JNPR
56
-2
VTR
55
-2
JNJ
38
-3
CNP
52
5
PM
56
-2
MMC
65
3
PLD
48
-2
Financhill
Back

Range Cancer Therapeutics ETF Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
47

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.24
Seasonality Move:
1.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Range Cancer Therapeutics ETF Stock Forecast

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 2.3% based on the past 9 years of stock performance.
  • Range Cancer Therapeutics ETF has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Range Cancer Therapeutics ETF Stock Undervalued?
    The current Range Cancer Therapeutics ETF [CNCR] share price is $15.09. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Range Cancer Therapeutics ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 2.3% based on the past 9 years of stock performance.

Range Cancer Therapeutics ETF Stock Rating

Sell
47
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF overpriced?

  • Range Cancer Therapeutics ETF has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Range Cancer Therapeutics ETF Stock Price History

Is CNCR stock going to rise?

  • The current trend is moderately bullish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
17.96
52-Week Low:
10.06

Prediction Charts

Market Cap:
0
Price in USD:
15.09
Volume:
2.2K
Beta:
1.11

Technical Analysis

SMA50:
15.07
SMA100:
14.77
SMA200:
15.09
52-Wk Change:
55.5%

Stock Predictions

  • Is Range Cancer Therapeutics ETF stock public?
    Yes, Range Cancer Therapeutics ETF is a publicly traded company.
  • What is the Range Cancer Therapeutics ETF stock quote today?
    The Range Cancer Therapeutics ETF stock price is 15.09 USD today.
  • How to buy Range Cancer Therapeutics ETF stock online?
    You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-24 14.91 14.84 15.10 14.84
Oct-25 14.85 14.69 14.85 14.69
Oct-28 15.05 15.29 15.34 15.05
Oct-29 15.11 15.03 15.11 14.99
Oct-30 14.90 14.90 14.90 14.90
Oct-31 14.87 14.58 14.87 14.58
Nov-1 14.67 14.74 14.78 14.67
Nov-4 14.96 14.96 14.96 14.96
Nov-5 15.01 15.16 15.16 15.01
Nov-6 15.59 15.59 15.73 15.46
Nov-7 15.73 15.80 15.91 15.73
Nov-8 15.70 15.72 15.72 15.56
Nov-11 15.94 15.74 15.94 15.59
Nov-12 15.53 15.09 15.53 15.29

Range Cancer Therapeutics ETF Earnings

Data Unavailable

Range Cancer Therapeutics ETF Forecast Revenue Growth

Data Unavailable

* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.